GT Biopharma Reports Fourth Quarter and Full-Year 2021 Finan

Presented novel TriKE® pre-clinical data driving NK cell immunotherapy against non-small cell lung cancer (NSCLC) in the hypoxic solid tumor microenvironment...

Related Keywords

Brisbane , Queensland , Australia , Corey Davis , David Castaneda , Jeffrey Miller , Michael Breen , Prnewswire Gt Biopharma Inc , Esmo Io Congress , Source Gt Biopharma Inc , Exchange Commission , Development Rd Expenses , Oncology Esmo Io Congress , European Society For Medical Oncology Immuno , University Of Minnesota , Gt Biopharma Inc , Company Tri , Executive Chairman , Interim Chief Executive , Anticancer Therapies , Chief Scientific Officer , European Society , Medical Oncology Immuno , Tri Specific Killer Engager , Year End , Relations Contacts , Gt Biopharma , Nc ,